J. Pagán Escribano , L. Castilla Guerra , E. Guitierrez-Sánchez , A. Gómez-Escobar , R. García Alonso , L. Arias-Barquet , O. Madridano Cobo , M. Martín Asenjo , E. Rubio Velázquez , A. Lorenzo Hernández , G. Puche Palao
{"title":"Position paper on retinal vein occlusion. SEMI-SERV","authors":"J. Pagán Escribano , L. Castilla Guerra , E. Guitierrez-Sánchez , A. Gómez-Escobar , R. García Alonso , L. Arias-Barquet , O. Madridano Cobo , M. Martín Asenjo , E. Rubio Velázquez , A. Lorenzo Hernández , G. Puche Palao","doi":"10.1016/j.rceng.2025.502307","DOIUrl":null,"url":null,"abstract":"<div><div>Retinal vein occlusion (RVO) is associated with both local and systemic factors such as hypertension, diabetes mellitus, dyslipidemia, and thrombophilias. In addition to specific recommendations for ophthalmological management, a comprehensive systemic approach is crucial, with rigorous control of cardiovascular risk factors, which are implicated in approximately 90% of RVO cases. In cases where it is necessary, an in-depth differential diagnosis should also be performed. This position paper aims to provide a thorough review of this common condition, including its pathophysiology, clinical manifestations, diagnosis, and treatment, based on the latest scientific evidence and expert recommendations.</div></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"225 6","pages":"Article 502307"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2254887425000591","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Retinal vein occlusion (RVO) is associated with both local and systemic factors such as hypertension, diabetes mellitus, dyslipidemia, and thrombophilias. In addition to specific recommendations for ophthalmological management, a comprehensive systemic approach is crucial, with rigorous control of cardiovascular risk factors, which are implicated in approximately 90% of RVO cases. In cases where it is necessary, an in-depth differential diagnosis should also be performed. This position paper aims to provide a thorough review of this common condition, including its pathophysiology, clinical manifestations, diagnosis, and treatment, based on the latest scientific evidence and expert recommendations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
